+
Site Tour

Search

  • Patients who benefit

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  The Amplatzer™ Talisman™ PFO Occluder is indicated for percutaneous transcatheter…

  • Overview

    Aortic Stenosis is the narrowing of the aortic orifice, typically as a result of degeneration and calcification of the valve leaflets.2 A normal aortic valve has an orifice of 3 to 4 cm.2,12…

  • Overview

    MITRAL VALVE DISEASE Mitral Regurgitation (MR) occurs when the mitral valve leaflets fail to properly close during ventricular contraction (systole) so blood flows back into the left atrium, leading…

  • Overview

    Heart Failure Heart failure is the gradual loss of the heart’s ability to pump enough blood to supply the body’s needs. Sometimes this condition is called congestive heart failure, because the body…

  • Master™ Features

    MASTERS™ SERIES IMPLANTABILITY OPTIONS WITH MASTERS™ SERIES The Masters™ series mechanical heart valves are rotatable, bileaflet valves designed for secure implantation.11 The portfolio includes…

  • Guidelines

    2016 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPED IN COLLABORATION WITH THE EUROPEAN ASSOCIATION OF CARDIOTHORACIC SURGERY (EACTS)¹ ACCESS TO…

  • Features

    THE TRICUSPID VALVE HAS FINALLY MET ITS MATCH TRICLIP™ G4 TEER SYSTEM. UNMATCHED STABILITY, PRECISION, CONTROL.2 The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable…

  • Features

    Features DESIGNED FOR THE MITRAL ANATOMY TO ELIMINATE MR TENDYNE™ eLABELLING SITE TREAT MORE MR IMPLANT WITH CONFIDENCE1 A wide array of sizes to provide appropriate fit for paravalvular…

  • Medical Management

    Traditional medical management of MR (both PMR and SMR) may, to an extent, relieve the symptoms of the condition, but is often insufficient at controlling the severity and progression of MR.21 ©…

  • Guidelines & Recommendations

    Compelling data resulted in positive guidelines recommending PFO closure Long-term data from the both the RESPECT trial12 and REDUCE trial,13 as well as data from the CLOSE trial,14 have revealed…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline